Industry News
Related Searches:
Filter by:
1456 - 1470 of 2387 results
February 25, 2009
Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) will restructure in an effort to grow the pharmaceutical business worldwide.
Read More »
February 23, 2009
Orexo AB will acquire PharmaKodex Ltd., a UK-based drug delivery company with several ready-to-partner preclinical and early clinical projects focused on improving oral, sublingual and transdermal medication.
Read More »
February 20, 2009
UCB plans to build a biologics pilot plant at its site Braine-l'Alleud in Belgium, as part of the company's efforts to focus on central nervous system (CNS) and immunology.
Read More »
February 20, 2009
Shire has signed a $70 million agreement with UCB to acquire the worldwide rights to Equasym IR and XL (methylphenidate hydrochloride), excluding the U.S., Canada and Barbados, for the treatment of ADHD.
Read More »
February 20, 2009
Therapure BioPharma, Inc. has been selected by LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for a plasma therapeutic protein.
Read More »
February 19, 2009
A new study conducted by IBM and Silico Research showed that biopharmaceutical companies that do not partner or collaborate with other companies, risk delays in the production of new medicines, medical devices, diagnostics and support services.
Read More »
February 18, 2009
Almac Clinical Services opened an additional storage facility at its EU headquarters in Craigavon for cold-chain and controlled clinical supply storage.
Read More »
February 18, 2009
PharmaNet Development Group opened a new office in Sao Paulo, Brazil. The new office is part of the company's efforts to provide services in this region, which is considered to be a desired location for clinical research due to its qualified investigators
Read More »
February 13, 2009
WIL Research Laboratories has acquired Midwest BioResearch (MBR). The two companies will integrate their service offerings and share best practices and marketing.
Read More »
February 13, 2009
Portola Pharmaceuticals has entered into an exclusive worldwide license agreement with Novartis. Novartis will develop and commercialize Portola's intravenous (i.v.) and oral P2Y12 ADP receptor antagonist, elinogrel, currently in Phase II as a potential a
Read More »
February 12, 2009
Merck has entered into an agreement with Insmed, Inc. to purchase its portfolio of follow-on biologic therapeutic candidates and its commercial manufacturing facilities in Boulder, CO for $130 million in cash.
Read More »
February 12, 2009
OctoPlus N.V. has signed a pharmaceutical development contract with Galapagos N.V.
Read More »
February 6, 2009
Idenix Pharmaceuticals has entered a license agreement granting GlaxoSmithKline (GSK) exclusive worldwide rights to IDX899, a non-nucleoside reverse transcriptase inhibitor (NNRTI) in Phase II clinical development for the treatment of HIV/AIDS.
Read More »
February 5, 2009
MiddleBrook Pharmaceuticals has retained Almac Pharma Services to provide packaging services for physician samples of Moxatag (amoxicillin extended-release) Tablets. Almac will work closely with MiddleBrook's commercial manufacturer, STADA Production Irel
Read More »
February 5, 2009
Compass Pharma Services LLC is now offering contract pharmaceutical packaging customers new microfilling capabilities for pouches, vials, blister packages and diagnostic medical devices.
Read More »
1456 - 1470 of 2387 results
